AML/MDS

Clinical trials for AML/MDS explained in plain language.

Never miss a new study

Get alerted when new AML/MDS trials appear

Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Engineered immune cells take aim at Hard-to-Treat leukemia

Disease control Ongoing

This early-phase study tests SENTI-202, a ready-made immune cell therapy, in people with certain blood cancers (like AML and MDS) that have come back or not responded to treatment. The therapy uses specially designed natural killer (NK) cells to find and attack cancer cells while…

Matched conditions: AML/MDS

Phase: PHASE1 • Sponsor: Senti Biosciences • Aim: Disease control

Last updated May 17, 2026 08:03 UTC

AML/MDS

Get alerted when new AML/MDS trials appear

Engineered immune cells take aim at Hard-to-Treat leukemia